RxDoctor Payments Data

Cory Edgar, PA

Medical · Orlando, FLNPI 1316336076

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $31,170 of the $40,921 with a category attached, or 76.2%. Takeda Pharmaceuticals U.S.A., Inc. accounts for 75.3% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $26,184 and has fallen 75.6% since, to $6,377 in 2024. Among medical clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$40,921in general payments, 2019–2025

Across 79 payments — averaging $517.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$31K
  • Jazz Pharmaceuticals Inc.$9K
  • Incyte Corporation$359
  • Astellas Pharma US Inc$269
  • Stemline Therapeutics Inc.$197
  • Dova Pharmaceuticals$40
  • plus $59 from 2 others
$23,216in research payments, 2019–2025

Across 3 payments — averaging $7738.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Incyte Corporation$23K

What the payments were for

  • Consulting fees$1,2403%
  • Speaking & faculty fees$31,17076%
  • Travel & lodging$6,41616%
  • Food & beverage$1,6434%
  • Education$4511%

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$40,921 in reported general payments places this provider in the 95th percentile of 2,031 medical providers in Florida.

See all medical providers in Florida

Medicare billing

Part B allowed, 2024
$10,300
Medicare patients
45
Services billed
94

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →